Skip to main content
All lobbying filings

BGR GOVERNMENT AFFAIRS

Lobbying for NEUROCRINE BIOSCIENCES, INC. · Biotechnology company

 Filing 1st Quarter - Amendment
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $60,000.00 income · posted Apr 20, 2026

Official filing document

 Lobbying activity 1
Pharmacy

Provide guidance and strategic counsel with regard to regulations and legislation that could impact the biopharmaceutical industry generally such as drug pricing and telehealth policy

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem